Cadila launches lung cancer drug at Rs 40000 per courseNDTVThe company, which spent 15 years in developing the drug for treatment of non-small-cell lung carcinoma (NSCLC), is looking to sell the drug in 50 countries in Africa and South East Asia apart …
|
SCT, AB Biosciences Collaborate on Antibodies Using NGS
GenomeWeb NEW YORK (GenomeWeb News) – Single Cell Technology and AB Biosciences today announced a collaboration aimed at identifying therapeutic antibodies. SCT will use its technology called Antibody Biologix to massively screen plasma cells and measure … Single Cell Technology and AB Biosciences Announce CollaborationHispanicBusiness.com |
Bhabha surgery department shows the way for BMC hospitalsTimes of IndiaMUMBAI: To most Mumbaikars who believe complicated surgeries relating to pancreatic or liver cancer can only be performed in medical schools or five-star hospitals, it may come as a…
NoozhawkBreaking the Code: UCSB Researchers Link Antibodies to Certain DiseasesNoozhawkBy cross referencing the amino acid sequence of peptides strongly associated with illnesses with a library of known peptides, researchers may be able to map antigens…
Creating biochemical reagents that can accurately detect disease-associated …Phys.OrgBy cross-referencing the amino acid sequence of peptides strongly associated with illnesses with a library of known peptides, researchers may be able to map antigens…
Business StandardCadila to sell cheaper lung cancer drug in India by DecBusiness StandardMycidac-C is for patients suffering from non-small cell lung cancer (NSCLC). Modi said the drug test showed it improved survival possibilities by 28.2 per cent and…
Times of India |
Old smokers who quit reap heart benefits faster
Times of India A new study led by Indian origin researcher has suggested that cigarette smokers who are over 65 years of age may be able to lower their risk of cardiovascular disease-related deaths to the level of never-smokers when they quit faster than previously … Smokers who quit may cut heart risk faster than had been thoughtDaily News & Analysis |
Newstrack India |
Cadila Pharma launches new lung cancer drug
The Hindu The new drug has been licensed and approved by the Drug Controller General of India (DCGI). Mycidac-C is meant for patients suffering from non-small cell lung cancer (NSCLC). “The drug is affordable, and is many times cheaper than what out competitors … Ancestor of TB germ to fight lung cancerCalcutta Telegraph Cadila Pharma launches affordable drugs for lung cancerNewstrack India Cadila launches low-cost cancer drugTimes of India Jagran Josh –India.Com Health all 22 news articles » |
|
Cadila Pharma to debut novel lung cancer drug Mycidac-C in India
The Pharma Letter Cadila Pharmaceuticals, one of India’s largest privately-held pharmaceuticals company, has launched for the first time in the world, Mycidac-C, an affordable, unique and innovative drug for the treatment of lung cancer. Mycidac-C is an innovative … |
The Courier |
Mary honoured for ‘amazing legacy’ of organ donation
Salisbury Journal As she lay on a bed at the Wessex Neurological Centre in Southampton, sustained by a life-support machine, her husband Doug took the difficult decision that his wife of 36 years should become an organ donor. Mr Bowden, 59, from Lover, was one of the … Life-saving tour visits Loanhead storeMidLothian Advertiser Apollo chairman Prathap Reddy wants West Bengal to pass cadaver transplant actIndia.Com Health Stained glass windows stand as permanent tribute to Tayside’s organ donorsThe Courier |